Felix Feng: “When a symposium is named after you, you can pretty much just wax poetic up on stage.”

Keynote address at The Feng Symposium in May 2024

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

On May 18, 2024, Felix Feng, a leader in genitourinary cancer research, gave the keynote address at the inaugural symposium that bears his name. 

Feng died Dec. 10, 2024. He was 48. He is remembered by colleagues at UCSF Helen Diller Family Comprehensive Cancer Center and NRG Oncology in two obituaries in this issue.

“When a symposium is named after you, you can pretty much just wax poetic up on stage,” Feng said. “I’m gonna do that. And to all my mentees in the audience, I always tell you to give a crisp talk—one or two major take-home messages. I’m gonna break all those rules, okay?”

In his address at The Feng Symposium on Prostate Cancer Revolutions, Feng talks about his career, the people who supported him along the way, his mentors, and his mentees.

“As we reflect on Felix’s life and contributions to the field, we hope this Symposium serves as a tribute to his deep compassion and remarkable career,” says a memorial page on The Feng Symposium website. 

The video of his full remarks is available on the Cancer History Project.


This column features the latest posts to the Cancer History Project by our growing list of contributors

The Cancer History Project is a free, web-based, collaborative resource intended to mark the 50th anniversary of the National Cancer Act and designed to continue in perpetuity. The objective is to assemble a robust collection of historical documents and make them freely available.  

Access to the Cancer History Project is open to the public at CancerHistoryProject.com. You can also follow us on Twitter at @CancerHistProj, or follow our podcast.

Is your institution a contributor to the Cancer History Project? Eligible institutions include cancer centers, advocacy groups, professional societies, pharmaceutical companies, and key organizations in oncology. 

To apply to become a contributor, please contact admin@cancerhistoryproject.com.

YOU MAY BE INTERESTED IN

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login